Lv1
10 积分 2023-06-05 加入
A network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia
4天前
已完结
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases
5天前
已完结
Pharmacogenomic Clinical Support Tools for the Treatment of Depression
1个月前
已完结
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants
9个月前
已完结
抑郁症中西医结合诊疗专家共识
11个月前
已完结
功能代谢组学在中药抗抑郁机制研究中的策略及应用
11个月前
已完结
Current pharmacotherapy approaches and novel GABAergic antidepressant development in postpartum depression
1年前
已关闭
Progresses in GluN2A-containing NMDA Receptors and their Selective Regulators
1年前
已完结
多晶型药物的监管要求及其药学研究思考
1年前
已完结
The why, when, where, how, and so what of so-called rapidly acting antidepressants
1年前
已完结
皖公网安备34019202002308
